Codeine Plus Paracetamol Versus Placebo for PRK Post-operative Pain (NCT02625753) | Clinical Trial Compass
CompletedPhase 3
Codeine Plus Paracetamol Versus Placebo for PRK Post-operative Pain
Brazil40 participantsStarted 2014-11
Plain-language summary
Compare the use of codeine/paracetamol against placebo for pain control after cornea photorefractive keratectomy (PRK).
Who can participate
Age range20 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* older than 20 years
* spherical component between -1.00 and -5.00, with or without astigmatism
* cylindrical component up to 1.5D
* spherical anisometropia of less than or equal to 0.75D,
* cylindrical anisometropia of less than or equal to 0.5D,
* stable refraction errors (maximal variation of 0.5D in the spherical or cylindrical component during 1 year)
* amenable to follow-up for at least seven (7) days.
Exclusion Criteria:
* presence of active disease of allergic, inflammatory or infectious nature, in the ocular surface or its attachments
* previous ocular history (pathology, surgery or ocular trauma)
* best corrected visual acuity less than 20/25)
* autoimmune disease, or immunosuppression or Diabetes Mellitus
* pregnancy or lactation.
What they're measuring
1
Pain measured by visual-analog scale 24hour after PRK